An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan

Leqembi (lecanemab-irmb) - Biogen, Eisai

An Observational Study of LEQEMBI in Routine Clinical Practice in Taiwan (clinicaltrials.gov) - Oct 10, 2026 - P=N/A | N=100 | Not yet recruiting | Sponsor: Eisai Taiwan Inc.
New trial • Alzheimer's Disease • CNS Disorders

http://clinicaltrials.gov/ct2/show/NCT07869264

Oct 10, 2026